Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Carcinoma, Ductal, Pancreatic

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreae, F; Decristoforo, C; Helbok, A; Ocak, M; Radolf, T; Rangger, C; Virgolini, IJ; Von Guggenberg, E1

Other Studies

1 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Carcinoma, Ductal, Pancreatic

ArticleYear
Design and evaluation of novel radiolabelled VIP derivatives for tumour targeting.
    Anticancer research, 2013, Volume: 33, Issue:4

    Topics: Animals; Binding, Competitive; Carcinoma, Pancreatic Ductal; Cells, Cultured; CHO Cells; Cricetinae; Drug Design; Female; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Peptide Fragments; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Vasoactive Intestinal Peptide; Tissue Distribution; Vasoactive Intestinal Peptide

2013